No connection

Search Results

Corporate Score 75 Neutral

Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion

Mar 31, 2026 11:44 UTC
BIIB, APLS, ^GSPC
Short term

Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile